Medicared For All Logo

Andrew Allegretti in Boston, Massachusetts

Home Massachusetts Boston

Andrew Allegretti has Nephrology as his primary medical specialty. Their primary office is: 55 Fruit St in Boston, Massachusetts.

They're a part of the: Massachusetts General Physicians Organization Inc medical group which has around 3,048 members. You can call their office at 617-724-0287 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2010 (around 15 years of experience). They are listed as doing telehealth appointments.

Andrew S Allegretti Office Phone and Directions

Andrew Allegretti
Massachusetts General Physicians Organization Inc
55 Fruit St
Boston, Massachusetts 02114
617-724-0287

Patient Ratings
Please rate your experience with Andrew Allegretti below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 617-724-0287


Enter a starting address:


Healthcare Info for Andrew Allegretti

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2010
The Primary Medical Specialty for Andrew Allegretti is listed as: Nephrology
Approximate Years of Experience: 15
PAC (PECOS ID)#: 1355502741
NPI #: 1427378991
NPI Created On: 06/08/2010
NPI Last Updated Listed as: 05/21/2016
Primary Taxonomy Code: 207R00000X
License Number:
L-243795
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Harvard Pilgrim Health Care Inc.
  • Medicare

They are listed as accepting new patients.

Services and Procedures include:

  1. Hemodialysis procedure with one physician evaluation
  2. Dialysis procedure including one evaluation
  3. Dialysis services (2-3 physician visits per month), patient 20 years of age and older
  4. New patient office or other outpatient visit, typically 45 minutes
  5. Established patient office or other outpatient visit, typically 15 minutes
  6. Established patient office or other outpatient, visit typically 25 minutes
  7. Initial hospital inpatient care, typically 70 minutes per day
  8. Subsequent hospital inpatient care, typically 25 minutes per day
  9. Subsequent hospital inpatient care, typically 35 minutes per day
  10. Physician telephone patient service, 11-20 minutes of medical discussion
  11. Physician telephone patient service, 21-30 minutes of medical discussion

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $3,710

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: Payment relates to the development of a new product studied in NCT02770716 Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1. Product has not yet received approval, license or clearance.

Record ID:: 843407401

Being Disputed:: No

Product Related: Yes

Payments Total: $2,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: Payment relates to the development of a new product studied in NCT02770716 Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1. Product has not yet received approval, license or clearance.

Record ID:: 843407405

Being Disputed:: No

Product Related: Yes

Payments Total: $530

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: Payment relates to the development of a new product studied in NCT02770716 Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1. Product has not yet received approval, license or clearance.

Record ID:: 843407421

Being Disputed:: No

Product Related: Yes

Payments Total: $2,650

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: Payment relates to the development of a new product studied in NCT02770716 Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1. Product has not yet received approval, license or clearance.

Record ID:: 843407409

Being Disputed:: No

Product Related: Yes

Payments Total: $530

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: Payment relates to the development of a new product studied in NCT02770716 Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1. Product has not yet received approval, license or clearance.

Record ID:: 843407413

Being Disputed:: No

Product Related: Yes

Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: Payment relates to the development of a new product studied in NCT02770716 Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1. Product has not yet received approval, license or clearance.

Record ID:: 843407417

Being Disputed:: No

Product Related: Yes

Payments Total: $530

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: Payment relates to the development of a new product studied in NCT02770716 Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1. Product has not yet received approval, license or clearance.

Record ID:: 843407425

Being Disputed:: No

Product Related: Yes

Payments Total: $3,180

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: Payment relates to the development of a new product studied in NCT02770716 Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1. Product has not yet received approval, license or clearance.

Record ID:: 843407429

Being Disputed:: No

Product Related: Yes

Payments Total: $3,445

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: Payment relates to the development of a new product studied in NCT02770716 Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1. Product has not yet received approval, license or clearance.

Record ID:: 843407433

Being Disputed:: No

Product Related: Yes

Nephrology Professionals in Boston

1.
Tripta Kaur

800 Washington St
Boston, MA
Pratt Medical Group Inc

2.
Adina Voiculescu

45 Francis St
Boston, MA
Brigham And Women's Physicians Organization Inc

3.
Manish Maski

330 Brookline Ave
Boston, MA
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc

4.
Andrew Fenves

55 Fruit St
Boston, MA
Massachusetts General Physicians Organization Inc

5.
Erin Flanagin

800 Washington St
Boston, MA
Pratt Medical Group Inc

6.
Jonathon Schwartz MD

55 Fruit St
Boston, MA
Massachusetts General Physicians Organization Inc

Providers in Massachusetts General Physicians Organization Inc

1.Emily Aaronson

55 Fruit St
Boston Ma 02114-2696
Massachusetts General Physicians Organization Inc
Emergency Medicine

2.Matthew Abadir

81 Highland Ave
Salem Ma 01970-2714
Massachusetts General Physicians Organization Inc
Anesthesiology

3.Matthew Abadir

55 Fruit St
Boston Ma 02114-2696
Massachusetts General Physicians Organization Inc
Anesthesiology

4.Lauren Abbate Md

55 Fruit St
Boston Ma 02114-2696
Massachusetts General Physicians Organization Inc
Internal Medicine

5.Gerald Abbott

102 Endicott St
Danvers Ma 01923-3623
Massachusetts General Physicians Organization Inc
Diagnostic Radiology

6.Gerald Abbott

55 Fruit St
Boston Ma 02114-2696
Massachusetts General Physicians Organization Inc
Diagnostic Radiology

View all 3,048 members of Massachusetts General Physicians Organization Inc medical group


Medicared For All
Vote!
Share